BELGIUM — The European Federation of Pharmaceutical Industries and Associations (EFPIA), based in Brussels, has urged the European Commission to conduct a thorough assessment of the impact of its upcoming…
Read MoreCategory: Pharmaceuticals
Parkinson’s drug patent fight carries high stakes for patients, says FTC
USA — The patent dispute between Supernus and Sage Chemical over the Parkinson’s drug Apokyn has caught the attention of the Federal Trade Commission (FTC), which has expressed concerns over…
Read MoreChatGPT to debut at AACR annual meeting with insights on pharma data for medical professionals
USA — ChatGPT, a large language model trained by OpenAI, is set to debut in the world of medical meetings, starting with the American Association for Cancer Research (AACR) Annual…
Read MoreMerck and Viatris reach settlement agreement in diabetes drug patent dispute
USA — Rival drugmakers Merck and Viatris have reached an agreement in their patent dispute over diabetes drugs Januvia and Janumet, pending approval from a judge. Attorneys for both companies…
Read MoreFDA removes most doses of Ozempic from drug shortage list after Novo Nordisk resolves supply issues
USA — Novo Nordisk’s Ozempic, a treatment for type 2 diabetes and off-label for weight loss, is no longer on the FDA’s drug shortage list after months of limited supply.…
Read MorePharmacosmos expands global reach with launch of Monofer in Japanese market
JAPAN — Pharmacosmos, a pharmaceutical company based in Denmark, has announced the release of its intravenous treatment for iron deficiency anemia, Monofer (ferric derisomaltose), in Japan. The launch follows the…
Read MorePfizer recalls over 4 million packages of prescription migraine medicine voluntarily
USA — Pfizer has issued a recall for 4.2 million packages of Nurtec ODT, which is used to treat migraines in adults. The U.S. Consumer Product Safety Commission (CPSC) raised…
Read MoreSamsung Biologics invests in capacity expansion with fifth plant
SOUTH KOREA — Samsung Biologics, a CDMO, has announced that it will construct a fifth plant in response to growing market demand. The new facility, which is part of the…
Read MoreAmgen to reduce workforce by 450 in second round of layoffs for 2023
USA — Amgen Inc has announced its plans to cut 450 jobs, which constitutes less than 2% of its workforce. This marks the company’s second round of layoffs this year,…
Read MoreFDA advisory panel supports full approval of Pfizer’s COVID therapy
USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…
Read More